Q3 2024 Holdings
Filed 2024-11-13 | 38 holdings | $116.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Illumina Inc(ILMN) | COM | 452327109 | $15.5M | 119,196 | 13.4% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $14.7M | 368,665 | 12.7% |
| Geron Corp(GERN) | COM | 374163103 | $6.2M | 1,373,550 | 5.4% |
| Merus N V | COM | N5749R100 | $6.0M | 120,038 | 5.2% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $5.7M | 235,000 | 4.9% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $5.4M | 160,570 | 4.6% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $5.3M | 436,378 | 4.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $5.2M | 23,022 | 4.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.9M | 74,022 | 4.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.2M | 106,680 | 3.6% |
| Exscientia PLC | ADS | 30223G102 | $4.2M | 859,892 | 3.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $4.1M | 106,100 | 3.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $3.8M | 146,800 | 3.3% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $3.6M | 1,883,179 | 3.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.2M | 63,950 | 2.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.2M | 287,846 | 2.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.6M | 49,120 | 2.2% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $2.4M | 463,654 | 2.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $2.1M | 9,762 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.0M | 13,600 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8M | 154,522 | 1.5% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.7M | 64,200 | 1.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.6M | 102,984 | 1.4% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $1.1M | 493,584 | 0.9% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $784.3K | 49,082 | 0.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $760.2K | 10,815 | 0.7% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $756.2K | 1,166,952 | 0.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $714.8K | 31,585 | 0.6% |
| Bolt Projs Hldgs Inc | COM | 09769B107 | $665.8K | 811,952 | 0.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $514.7K | 10,875 | 0.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $331.1K | 7,300 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $238.7K | 7,450 | 0.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $233.1K | 430 | 0.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $212.2K | 3,820 | 0.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J200 | $129.8K | 185,475 | 0.1% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $125.2K | 37,247 | 0.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $100.2K | 47,936 | 0.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $76.3K | 41,950 | 0.1% |